Anti-PD-1 therapy-induced aGvHD is associated with abnormal IL-1β and NKG2A level in AML patients with relapse post-UCBT

Xiaoyu Zhu(Jiangsu Hengrui Medicine (China)), Li Xu(Fujian Medical University), Ping Qiang(University of Science and Technology of China), Jianbo Yang(Xinjiang Medical University), Xiaokang Dai(Anhui Medical University), Peidong Yan(University of Science and Technology of China), Jiajia Xie(University of Science and Technology of China), Yuting Wang(Rutgers, The State University of New Jersey), Chi Zhang(The University of Texas Southwestern Medical Center), Guangyu Sun(University of Science and Technology of China), Dongyao Wang(University of Science and Technology of China), Jin Xu, Bo Pan(University of Science and Technology of China)
Research Square
February 29, 2024
10.21203/rs.3.rs-3989489/v1
Cited by 0

Related Papers

A bibliometric analysis of operations research and management science
|Omega|2016|719
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms
|The Journal of Cell Biology|2004|148
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
|BMJ|2023|82
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
|Frontiers of Medicine|2021|80
Recycling and direct regeneration of valuable cathode materials from spent Li-ion batteries: a comprehensive review
|Journal of Materials Chemistry A|2025|40